🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
341 medicines starting with “F”
MedicineActive substanceLicence holderStatus
Flixotide Diskus 100 micrograms, Inhalation Powder, pre-dispensed
PA1077/044/010
Fluticasone propionate GlaxoSmithKline (Ireland) Limited Marketed
Flixotide Diskus 250 micrograms, Inhalation Powder, pre-dispensed
PA1077/044/011
Fluticasone propionate GlaxoSmithKline (Ireland) Limited Marketed
Flixotide Diskus 50 micrograms, Inhalation Powder, pre-dispensed
PA1077/044/009
Fluticasone propionate GlaxoSmithKline (Ireland) Limited Marketed
Flixotide Diskus 500 micrograms, Inhalation Powder, pre-dispensed
PA1077/044/012
Fluticasone propionate GlaxoSmithKline (Ireland) Limited Marketed
Flixotide Evohaler 125 micrograms per metered dose Pressurised Inhalation Suspension
PA1077/044/014
Fluticasone propionate GlaxoSmithKline (Ireland) Limited Marketed
Flixotide Evohaler 125 micrograms per metered dose Pressurised Inhalation Suspension
PPA1463/260/001
Fluticasone propionate IMED Healthcare Ltd.,
Flixotide Evohaler 125 micrograms per metered dose pressurised inhalation, suspension
PPA0465/073/001
Fluticasone propionate PCO Manufacturing Ltd.
Flixotide Evohaler 250 micrograms per metered dose Pressurised Inhalation Suspension
PPA1463/260/002
Fluticasone propionate IMED Healthcare Ltd.,
Flixotide Evohaler 250 micrograms per metered dose pressurised inhalation, suspension
PPA0465/073/002
Fluticasone propionate PCO Manufacturing Ltd.
Flixotide Evohaler 250 micrograms per metered dose Pressurised Inhalation, Suspension
PA1077/044/015
Fluticasone propionate GlaxoSmithKline (Ireland) Limited Marketed
Flixotide Evohaler 50 micrograms per metered dose pressurised inhalation, suspension
PPA0465/073/005
Fluticasone propionate PCO Manufacturing Ltd.
Flixotide Evohaler 50 micrograms per metered dose, Pressurised Inhalation Suspension
PA1077/044/013
Fluticasone propionate GlaxoSmithKline (Ireland) Limited Marketed
Flolan 0.5 mg powder and solvent for solution for infusion
PA1077/058/002
Epoprostenol GlaxoSmithKline (Ireland) Limited Marketed
Flolan 1.5 mg powder and solvent for solution for infusion
PA1077/058/001
Epoprostenol GlaxoSmithKline (Ireland) Limited Marketed
Floxapen 1000 mg powder for solution for injection or infusion
PA1986/111/003
Flucloxacillin Teva B.V. Marketed
Floxapen 2000 mg powder for solution for injection or infusion
PA1986/111/004
Flucloxacillin Teva B.V. Marketed
Floxapen 250mg Powder for solution for Injection or Infusion
PA1986/111/001
Flucloxacillin Teva B.V. Marketed
Floxapen 500 mg Powder for Solution for Injection or Infusion
PA1986/111/002
Flucloxacillin Teva B.V. Marketed
Fluad suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuvanted)
EU/1/24/1878/001-004
A/(H1N1)-LIKE VIRUS ANTIGEN, A/(H3N2)-LIKE VIRUS ANTIGEN, B (Victoria lineage)-like virus antigen Seqirus Netherlands B.V.
Fluarix Tetra suspension for injection in pre-filled syringe Influenza vaccine (split virion, inactivated)
PA1077/134/001
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/6/2021, IVR-227), B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, BVR-26) [Victoria lineage], B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE) GlaxoSmithKline (Ireland) Limited Not marketed
Flucelvax suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
EU/1/24/1879/001-004
A/(H1N1)-LIKE VIRUS ANTIGEN, A/(H3N2)-LIKE VIRUS ANTIGEN, B (Victoria lineage)-like virus antigen Seqirus Netherlands B.V.
Flucillin – Flucloxacillin Capsules 250 mg
PA0281/031/004
Flucloxacillin Pinewood Laboratories Ltd Marketed
Flucillin – Flucloxacillin capsules 500 mg
PA0281/031/005
Flucloxacillin Pinewood Laboratories Ltd Marketed
Flucloxacillin 1000 mg Film-coated Tablets
PA22871/026/002
FLUCLOXACILLIN SODIUM Azure Pharmaceuticals Ltd. Not marketed
Flucloxacillin 1000 mg powder for solution for injection or infusion
PA25636/001/002
FLUCLOXACILLIN SODIUM Antibiotice S.A. Not marketed
Flucloxacillin 1000 mg powder for solution for injection/infusion
PA2059/069/002
FLUCLOXACILLIN SODIUM Fresenius Kabi Deutschland GmbH Marketed
Flucloxacillin 1000 mg powder for solution for injection/infusion
PA1122/036/002
Flucloxacillin sodium monohydrate Noridem Enterprises Limited Not marketed
Flucloxacillin 1000 mg Powder for solution for injection/infusion
PA1862/003/003
Flucloxacillin Ibigen Srl Marketed
Flucloxacillin 125 mg/5 ml Powder for Oral Solution, Sugar Free
PA22749/024/001
FLUCLOXACILLIN SODIUM Brillpharma (Ireland) Limited Not marketed
Flucloxacillin 125mg/5ml Oral Solution
PA1418/016/003
Flucloxacillin Athlone Pharmaceuticals Limited Marketed
Flucloxacillin 125mg/5ml Oral Solution BP
PA1418/015/001
Flucloxacillin Athlone Pharmaceuticals Limited Not marketed
Flucloxacillin 1g Powder for Solution for Injection or Infusion
PA0281/228/003
Flucloxacillin sodium monohydrate Pinewood Laboratories Ltd Not marketed
Flucloxacillin 2000 mg powder for solution for injection/infusion
PA1862/003/004
Flucloxacillin Ibigen Srl Marketed
Flucloxacillin 2000 mg powder for solution for injection/infusion
PA2059/069/003
FLUCLOXACILLIN SODIUM Fresenius Kabi Deutschland GmbH Marketed
Flucloxacillin 2000 mg powder for solution for injection/infusion
PA1122/036/003
Flucloxacillin sodium monohydrate Noridem Enterprises Limited Not marketed
Flucloxacillin 250 mg Capsules
PA0298/016/001
Flucloxacillin Athlone Laboratories Limited Not marketed
Flucloxacillin 250 mg Capsules
PA1418/016/001
Flucloxacillin Athlone Pharmaceuticals Limited Marketed
Flucloxacillin 250 mg Powder for solution for injection/infusion
PA1862/003/001
Flucloxacillin Ibigen Srl Marketed
Flucloxacillin 250 mg/5 ml Powder for Oral Solution, Sugar Free
PA22749/024/002
FLUCLOXACILLIN SODIUM Brillpharma (Ireland) Limited Not marketed
Flucloxacillin 250mg Powder for Solution for Injection or Infusion
PA0281/228/001
Flucloxacillin sodium monohydrate Pinewood Laboratories Ltd Not marketed
Flucloxacillin 250mg/5ml Oral Solution
PA1418/016/004
Flucloxacillin Athlone Pharmaceuticals Limited Marketed
Flucloxacillin 500 mg capsules
PA0298/016/002
Flucloxacillin Athlone Laboratories Limited Marketed
Flucloxacillin 500 mg capsules
PA1418/016/002
Flucloxacillin Athlone Pharmaceuticals Limited Marketed
Flucloxacillin 500 mg film-coated tablets
PA22871/026/001
FLUCLOXACILLIN SODIUM Azure Pharmaceuticals Ltd. Marketed
Flucloxacillin 500 mg powder for solution for injection or infusion
PA25636/001/001
Flucloxacillin Antibiotice S.A. Not marketed
Flucloxacillin 500 mg powder for solution for injection/infusion
PA2059/069/001
FLUCLOXACILLIN SODIUM Fresenius Kabi Deutschland GmbH Marketed
Flucloxacillin 500 mg powder for solution for injection/infusion
PA1122/036/001
Flucloxacillin sodium monohydrate Noridem Enterprises Limited Not marketed
Flucloxacillin 500 mg Powder for solution for injection/infusion
PA1862/003/002
Flucloxacillin Ibigen Srl Marketed
Flucloxacillin 500mg Powder for Solution for Injection or Infusion
PA0281/228/002
Flucloxacillin sodium monohydrate Pinewood Laboratories Ltd Not marketed
Flucol 150 mg hard capsules
PA0711/057/003
Fluconazole Rowex Limited, Marketed
1 2 3 4 5 6 7

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.